VWR Acquires United Biochemicals
News Jul 05, 2013
Based in Sanborn, New York and founded in 1996, United Biochemicals manufactures and supplies high purity buffers and biochemicals for research, development and manufacturing processes to biotech, pharmaceutical, cell culture media and medical diagnostic industries.
"United Biochemicals is a strong compliment to VWR's growing life sciences portfolio as VWR continues to make strategic investment into our business," said Manuel Brocke-Benz, President and CEO of VWR. "United Biochemicals' manufacturing expertise, combined with VWR's existing platform of chemical manufacturing assets, enhances our current offering to our biotech and pharmaceutical customers and strengthens our position in the industry."
"We are excited to join a trusted, global brand like VWR," shared Fayyaz Hussain, President of United Biochemicals. "This acquisition will allow United Biochemicals to leverage VWR's global sales and marketing organization to grow our business."
Financial details of this acquisition remain confidential.
CRISPR Used to Prevent Development of Angiogenesis of the RetinaNews
Powerful new technology may lead to novel therapies to prevent vision loss, blindness in those with diseases of the retina.READ MORE
Understanding the Cellular Systems that Hold Back the Spread of CancerNews
Scientists have uncovered how cells are kept in the right place as the body develops, which may shed light on what causes invasive cancer cells to migrate.READ MORE
Comments | 0 ADD COMMENT
Theme: Gathering the Newborn Advances in Cardiology
Mar 19 - Mar 20, 2018